Navigation Links
Lloydspharmacy Reveals Couples Beleaguered by Monthly Cramps
Date:12/24/2010

COVENTRY, England, Dec. 24, 2010 /PRNewswire/ -- New research from Lloydspharmacy reveals that whilst an overwhelming number of women suffer from menstrual cramps, male partners' sympathy levels at that time of the month appear to be lacking. Although 87% of men claim to be very or fairly compassionate, a quarter of women (25%) who have suffered discomfort with 'Mother Nature's gift' say their partners are unsympathetic.

The survey shows that period pain plagues nine in 10 women (89%) yet one in five (19%) has suffered in silence at home because of an unsympathetic partner. However it may be a case of actions speaking louder than words as, although many men claim to be considerate, nearly half (42%) admitted they try to stay out of their partner's way when 'aunt dot' comes to stay.

In light of this, it is unsurprising that one in six (16%) women said that period pain has resulted in an argument with their partner.  This is especially true for those women who suffer severe pain every month, with:

- Nearly two thirds (61%) stating their period is extremely or very painful

- Half said they've been doubled over in pain

- One in five have been physically sick

- A quarter have taken sick leave from work

Melinda Setanoians, prescribing pharmacist at Lloydspharmacy, said: "Many women clearly suffer quite badly – so much so that it appears to be affecting the harmony of their relationships. There is a wide choice of painkillers available but some women prefer an alternative to medication or a way in which to supplement it. We are the only high street retailer in the UK to offer a highly effective, drug-free period pain reliever device. It uses TENS technology to ease pain, similar to the machines that people use for back pain and that women use in the early stages of childbirth."

The Lloydspharmacy Period Pain Reliever uses TENS (transcutaneous electrical nerve stimulation) technology to alleviate pain. It works by passing harmless electrical signals into the body to relieve pain by blocking the body's pain signals and stimulating the body to produce endorphins, people's own natural pain relief.

Approved by Action on Pain, the Lloydspharmacy Period Pain Reliever is small, discreet and lightweight, with the main unit clipping securely to clothing or underwear.

Notes to editors:

All figures, unless otherwise stated, are from YouGov Plc.  Total sample size was 2157 adults. Fieldwork was undertaken between 22nd - 25th October 2010.  The survey was carried out online. The figures have been weighted and are representative of all GB adults (aged 18+).

About Lloydspharmacy

Lloydspharmacy has an online pharmacy and online doctor as well as over 1650 pharmacies across the UK. These are based predominantly in community and health centre locations.  The company employs over 17,000 staff and dispenses over 151 million prescription items annually.For further media information please contact:Claire ConnollyLloydspharmacy Press OfficeSapphire CourtWalsgrave TriangleCoventryCV2 2TX02476 432192www.lloydspharmacy.com
'/>"/>

SOURCE Lloydspharmacy
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
2. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
3. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
4. Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals
5. Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
6. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
7. Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R)
8. MultiVu Video Feed: Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA
9. Nationwide Progress Poll Reveals Increased Efforts by Hospitals to Control MRSA Infection
10. As Summer Heats Up, New Survey Reveals Need for Effective Sweat Treatments
11. Stroke Study Reveals a Key Target For Improving Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... 25,2016 FDA 510(k) clearance ... platform for urological and surgical applications ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) ... the US with the 12 th 510(k) ... (FDA). This new FDA clearance covers Confocal Miniprobes ...
(Date:5/25/2016)... , May 25, 2016  According to Kalorama ... $381 billion in 2015.  Though these are challenging ... of opportunity for success for companies that remain ... search of new growth prospects medical device companies ... research and development (R&D) than do companies in ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent ... for drugs, biologics, consumer health and global clinical supply services, today announced two ... support the company’s continued investment and strategic growth plans in the Asia Pacific ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... supply chain solutions, today announced the organization has earned its ISO 13485 certification, ... and is compliant with all rules and policies associated with ISO quality standard ...
(Date:5/26/2016)... New York, NY (PRWEB) , ... May 26, ... ... cell researcher, founder of Mehling Orthopedics and chief medical officer of Blue Horizon ... Musculoskeletal Disease and Regeneration. The conference was held during May 5-6, 2016 in ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... to oncology professionals, has added National Cancer Institute-designated University of Virginia (UVA) ... In this new partnership, OncLive’s editorial and marketing teams will publicize and promote ...
(Date:5/26/2016)... ... May 26, 2016 , ... Metcalf & ... over 20 years of experience in leading technology and human resources operations for ... university teaching, Morrow-Fox will be featured on Metcalf’s VoiceAmerica radio show , ...
Breaking Medicine News(10 mins):